TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

被引：0
|
作者：
Ying Xing
Yuechao Liu
Tianbo Liu
Qingwei Meng
Hailing Lu
Wei Liu
Jing Hu
Chunhong Li
Mengru Cao
Shi Yan
Jian Huang
Ting Wang
Li Cai
机构：
[1] Harbin Medical University Cancer Hospital,The Fourth Department of Medical Oncology
[2] Harbin Medical University Cancer Hospital,Department of Gynecology
[3] Harbin Medical University,The Sixth Department of Medical Oncology
[4] Harbin Medical University Cancer Hospital,undefined
来源：
Cell Communication and Signaling | / 16卷
关键词：
TNFAIP8; NSCLC; Proliferation; Cisplatin chemoresistance; MDM2/p53 pathway;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway
    Xing, Ying
    Liu, Yuechao
    Liu, Tianbo
    Meng, Qingwei
    Lu, Hailing
    Liu, Wei
    Hu, Jing
    Li, Chunhong
    Cao, Mengru
    Yan, Shi
    Huang, Jian
    Wang, Ting
    Cai, Li
    CELL COMMUNICATION AND SIGNALING, 2018, 16
  • [2] mdm2 and p53 overexpression in non-small cell lung carcinomas
    Singh, B
    Li, Y
    Sachdev, R
    Greenebaum, E
    Ford, JG
    LABORATORY INVESTIGATION, 1997, 76 (01) : 1009 - 1009
  • [3] Association of p53 and mdm2 in the development and progression of non-small cell lung cancer
    Javid, Jamsheed
    Mir, Rashid
    Julka, P. K.
    Ray, P. C.
    Saxena, Alpana
    TUMOR BIOLOGY, 2015, 36 (07) : 5425 - 5432
  • [4] TopBPI contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53
    Lv, Yinxiang
    Huo, Yanan
    Yu, Xican
    Liu, Rongrong
    Zhang, Shufen
    Zheng, Xiaoxiao
    Zhang, Xianning
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3053 - 3064
  • [5] Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer
    Zheng, Datong
    Chen, Yanping
    Gao, Caijie
    Wei, Yongyue
    Cao, Guochun
    Lu, Nan
    Hou, Yayi
    Jiang, Xiuqin
    Wang, Jianjun
    CANCER BIOLOGY & THERAPY, 2014, 15 (11) : 1542 - 1551
  • [6] Combined Effect of Genetic Polymorphisms in P53, P73, and MDM2 on Non-small Cell Lung Cancer Survival
    Liu, Li
    Wu, Chen
    Wang, Ying
    Zhong, Rong
    Duan, Shengyu
    Wei, Sheng
    Lin, Songyi
    Zhang, Xinyu
    Tan, Wen
    Yu, Dianke
    Nie, Shaofa
    Miao, Xiaoping
    Lin, Dongxin
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1793 - 1800
  • [7] Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway
    Xu, Jianhao
    Ni, Liwei
    Zhao, Fenglun
    Dai, Xiaoxiao
    Tao, Jialong
    Pan, Jia
    Shi, Aiming
    Shen, Zhu
    Su, Cunjin
    Zhang, Yusong
    AGING-US, 2021, 13 (04): : 5986 - 6009
  • [8] Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2
    Tung, Min-Che
    Lin, Po-Lin
    Wang, Yao-Chen
    He, Tsung-Ying
    Lee, Ming-Ching
    Yeh, Sauh-Der
    Chen, Chih-Yi
    Lee, Huei
    ONCOTARGET, 2015, 6 (39) : 41692 - 41705
  • [9] α-Hederin promotes ferroptosis and reverses cisplatin chemoresistance in non-small cell lung cancer
    Han, Shugao
    Yang, Xi
    Zhuang, Jing
    Zhou, Qing
    Wang, Jingjing
    Ru, Lixin
    Niu, Furong
    Mao, Wei
    AGING-US, 2024, 16 (02): : 1298 - 1317
  • [10] LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway
    Li, Yang
    Ma, Hong-Yu
    Hu, Xiao-Wei
    Qu, Yuan-Yuan
    Wen, Xin
    Zhang, Yu
    Xu, Qing-Yong
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
12345